PUBLICATION
Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer
- Authors
- Schneider, J.A., Craven, T.W., Kasper, A.C., Yun, C., Haugbro, M., Briggs, E.M., Svetlov, V., Nudler, E., Knaut, H., Bonneau, R., Garabedian, M.J., Kirshenbaum, K., Logan, S.K.
- ID
- ZDB-PUB-181026-4
- Date
- 2018
- Source
- Nature communications 9: 4396 (Journal)
- Registered Authors
- Knaut, Holger
- Keywords
- none
- MeSH Terms
-
- Animals
- Cell Line, Tumor
- Cell Proliferation/drug effects
- Embryo, Nonmammalian/metabolism
- Eye/embryology
- HEK293 Cells
- Humans
- Macrocyclic Compounds/pharmacology*
- Male
- Peptides/pharmacology*
- Peptoids/pharmacology*
- Phenotype
- Prostatic Neoplasms/metabolism*
- Prostatic Neoplasms/pathology
- Protein Binding/drug effects
- Receptors, Androgen/metabolism
- Spheroids, Cellular/drug effects
- Spheroids, Cellular/metabolism
- Spheroids, Cellular/pathology
- TCF Transcription Factors/metabolism*
- Wnt Signaling Pathway
- Zebrafish/embryology
- beta Catenin/metabolism*
- PubMed
- 30352998 Full text @ Nat. Commun.
Citation
Schneider, J.A., Craven, T.W., Kasper, A.C., Yun, C., Haugbro, M., Briggs, E.M., Svetlov, V., Nudler, E., Knaut, H., Bonneau, R., Garabedian, M.J., Kirshenbaum, K., Logan, S.K. (2018) Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer. Nature communications. 9:4396.
Abstract
New chemical inhibitors of protein-protein interactions are needed to propel advances in molecular pharmacology. Peptoids are peptidomimetic oligomers with the capability to inhibit protein-protein interactions by mimicking protein secondary structure motifs. Here we report the in silico design of a macrocycle primarily composed of peptoid subunits that targets the β-catenin:TCF interaction. The β-catenin:TCF interaction plays a critical role in the Wnt signaling pathway which is over-activated in multiple cancers, including prostate cancer. Using the Rosetta suite of protein design algorithms, we evaluate how different macrocycle structures can bind a pocket on β-catenin that associates with TCF. The in silico designed macrocycles are screened in vitro using luciferase reporters to identify promising compounds. The most active macrocycle inhibits both Wnt and AR-signaling in prostate cancer cell lines, and markedly diminishes their proliferation. In vivo potential is demonstrated through a zebrafish model, in which Wnt signaling is potently inhibited.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping